As of Oct 20
| -0.18 / -1.59%|
The 6 analysts offering 12-month price forecasts for Lexicon Pharmaceuticals Inc have a median target of 24.00, with a high estimate of 38.00 and a low estimate of 11.30. The median estimate represents a +115.05% increase from the last price of 11.16.
The current consensus among 7 polled investment analysts is to Buy stock in Lexicon Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.